Stay updated with breaking news from Codexis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com downgraded shares of Codexis (NASDAQ:CDXS – Free Report) from a hold rating to a sell rating in a report released on Tuesday morning. Several other analysts have also recently weighed in on CDXS. Stifel Nicolaus dropped their price objective on shares of Codexis from $9.00 to $5.00 and set a buy rating for the […]
REDWOOD CITY, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced Stephen...
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) insider Margaret Nell Fitzgerald purchased 11,834 shares of the stock in a transaction that occurred on Friday, September 8th. The stock was purchased at an average price of $1.70 per share, for a total transaction of $20,117.80. Following the acquisition, the insider now owns 81,420 shares in the […]
On September 11, 2023, Kevin Norrett, the COO of Codexis Inc (NASDAQ:CDXS), made a significant insider purchase of 9,000 shares of the company's stock.
Analysts’ upgrades for Monday, September 11th: Accenture (NYSE:ACN) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. Antero Midstream (NYSE:AM) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. Ascendis Pharma A/S (NASDAQ:ASND) was upgraded by analysts at StockNews.com from a sell rating to a […]